Adoptive antitumor immunotherapy in vitro and in vivo using genetically activated erbB2-specific T cells.
第一作者:
Chaoyan,Wang
第一单位:
*Zhejiang Provincial Key Laboratory of Medical Genetics, School of Life Science ‡The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang †Xuanwu Hospital, Capital Medical University, Beijing, P.R. China.
作者:
主题词
动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);疾病模型, 动物(Disease Models, Animal);电穿孔(Electroporation);基因表达(Gene Expression);人类(Humans);免疫组织化学(Immunohistochemistry);免疫疗法, 过继(Immunotherapy, Adoptive);淋巴细胞活化(Lymphocyte Activation);肿瘤(Neoplasms);重组融合蛋白质类(Recombinant Fusion Proteins);T细胞抗原受体特异性(T-Cell Antigen Receptor Specificity);T淋巴细胞(T-Lymphocytes);转染(Transfection);肿瘤负荷(Tumor Burden);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1097/CJI.0000000000000048
PMID
25075564
发布时间
2017-11-16
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文